The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Https://investingstrategy.co.uk/stock-tips/why-do-some-ceos-remain-silent-as-the-share-price-tanks/
Great video giving an overall summary of ONDO. All seems rosy in the garden
https://www.youtube.com/watch?v=DCnGy-UCVkQ
I posted a message on here today, which was factual and it's been taken down.
Make your own mind up if you think this is justifiable.
Dark forces work on here, right from the 24/7 posters to the lse admin.
AVCT is here to stay despite what you scumbags think, over and out for me, this board is a waste of space.
These analysts are supposed to be intelligent and give the COS as 10%.
On the other hand AVCT spent an hour yesterday telling us it works.
WTF are these city boys up to?, they always state that at P1 it's 10%, BUT this is NOT acceptable for all companies.
They are big earning money, when a trained monkey could give a better answer.
Useless twats the lot of them.
AVCT science will WIN through.
This may be the reason why he's rushed the results out.
He's probably "pimping today.
Give him a chance, if you believe in the science hold.
If you don't then sell up.
If you trade, hope you get burnt, BUT you won't affect the ultimate goal of the company.
From slide 11 of presentation, looks like 2 weekly trial will start off at cohort 3 levels of 160 eq. dox. Then progress at dox eq. levels of cohort 4 to 6 (total of 4 cohorts).
Disease surveillance is every 8 weeks, so I can see this taking a little longer than the 6 months previously stated by AS.
Bit of jealousy on here against someone who has a bit of money. If he was just a trader, would he have done this?
https://www.lse.co.uk/rns/BSFA/standard-form-for-notification-of-major-holdings-eyduqlhbknp37gw.html
Don,t think so